Over-the-counter drug products containing colloidal silver ingredients or silver salts.  Department of Health and Human Services (HHS), Public Health Service (PHS), Food and Drug Administration (FDA).  Final rule.
The Food and Drug Administration (FDA) is issuing a final rule establishing that all over-the-counter (OTC) drug products containing colloidal silver ingredients or silver salts for internal or external use are not generally recognized as safe and effective and are misbranded.  FDA is issuing this final rule because many OTC drug products containing colloidal silver ingredients or silver salts are being marketed for numerous serious disease conditions and FDA is not aware of any substantial scientific evidence that supports the use of OTC colloidal silver ingredients or silver salts for these disease conditions.
D003102:Colloids; D017277:Drug Approval; D004348:Drug Labeling / Q000331:legislation & jurisprudence*; D006801:Humans; D007880:Legislation, Drug; D004366:Nonprescription Drugs; D012492:Salts; D012834:Silver; D014481:United States; D014486:United States Food and Drug Administration
D003102:Colloids; D004366:Nonprescription Drugs; D012492:Salts; D012834:Silver